Case Report: Pseudomonas can take a toll on a patient

David K Buchbinder1, Jasjit Singh2, Tuan Dao3

  • 1Department of Hematology, CHOC Chidren's Hospital, Orange, CA, 92868, USA.

F1000Research
|October 11, 2021
PubMed

Insights

Severe Pseudomonas aeruginosa infections in children may indicate underlying inborn errors of immunity. Early diagnosis through immune function testing and genetic sequencing is crucial for effective treatment and supportive care.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Genetics

Background:

  • Pseudomonas aeruginosa (P. aeruginosa) is a Gram-negative bacterium causing severe infections in pediatric patients, including sepsis.
  • Host defense against P. aeruginosa involves innate immunity, particularly Toll-like receptors (TLRs) and cytokine production.
  • Inborn errors of immunity can predispose individuals to invasive P. aeruginosa infections.

Observation:

  • A previously healthy two-year-old female presented with invasive skin, soft tissue, and central nervous system infection due to P. aeruginosa.
  • Immune evaluation revealed a decreased cytokine response to TLR agonists.
  • Genetic analysis identified a homozygous deletion in IRAK-4, indicating IRAK-4 deficiency.

Findings:

  • The patient's severe P. aeruginosa infection was linked to a deficiency in interleukin-1 receptor-associated kinase (IRAK)-4.
  • IRAK-4 deficiency impairs the innate immune response, particularly TLR signaling and cytokine generation.
  • This case highlights a specific genetic defect predisposing to severe bacterial infections.

Implications:

  • Clinicians should consider inborn errors of immunity in all pediatric patients with severe P. aeruginosa infections.
  • Functional immune assessments combined with genetic sequencing enable timely diagnosis and management.
  • Identifying IRAK-4 deficiency allows for targeted treatment and appropriate supportive care, improving patient outcomes.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...